FDA•
Niacin Extended-release Tablets
Lannett is recalling 1,000 mg Niacin Extended-release Tablets due to failed dissolution specifications.
Filters
Category
Agency
Severity
Drugs Recalls
Back to home ←
FDA•Xyvona (levorphanol tartrate) 2mg TabletsForte BioPharma is recalling Xyvona (levorphanol tartrate) 2mg tablets due to the FDA's denial of the product's proprietary name.
2 products
FDA•LOWPred Mild Ophthalmic SuspensionAbbVie is recalling 10 mL bottles of Pred Mild ophthalmic suspension due to failed stability specifications.
FDA•LOWLidocaine HCl Injection 2%Eugia US LLC is recalling Lidocaine HCl Injection 2% single-dose vials because the label wrap obscures the barcode, preventing it from scanning.
FDA•ToxiBan Charcoal-Kaolin SuspensionLloyd Inc. is recalling ToxiBan Charcoal-Kaolin Suspension due to microbial levels exceeding specification limits.
FDA•LOWNicotine Transdermal System Patch 14 mgAveva is recalling 14 mg Nicotine Transdermal System Patches due to elevated levels of oxidative-related impurities.
FDA•LOWBusulfan InjectionSagent Pharmaceuticals is recalling Busulfan Injection (NDC 25021-241-10) due to failed impurities and degradation specifications.
FDA•LOWPrimidone Tablets 250 mgAmerican Health Packaging is recalling Primidone Tablets 250 mg due to cross-contamination with trace amounts of Acemetacin.
2 products
FDA•LOWPrimidone 50 mg TabletsGolden State Medical Supply is recalling Primidone 50 mg Tablets (NDC 51407-637-05) due to potential cross-contamination with Acemetacin.
2 products- FDA•LOWPrimidone 250mg Tablets
Lannett Company is recalling Primidone 250mg Tablets (NDC 0527-1231-01) due to potential cross-contamination with Acemetacin API.
FDA•LOWLevocarnitine Injection, USP 1 g/5 mLAmerican Regent is recalling Levocarnitine Injection 1 g/5 mL vials (NDC 0517-1045-01) due to missing label.
FDA•LOWMonsel's Ferric Subsulfate Solution 8 mLPremier Dental Products is recalling Monsel's Ferric Subsulfate Solution 8 mL vials (NDC 48783-112-08) due to incorrect expiration date on the vial label.
FDA•LOWBuspirone Hydrochloride Tablets 5 mgUnichem is recalling 500-count bottles of Buspirone Hydrochloride Tablets, 5 mg, due to subpotency.
FDA•LOWCVS Lidocaine Wound GelCVS is recalling Lidocaine Wound Gel (NDC 59898-950, 0.5 oz) due to failed pH specifications.
FDA•LOWAmprol 25% Medicated ArticleHuvepharma is recalling one bag of Amprol 25% medicated article due to missing lot number and expiration date information.
FDA•LOWMagnesium Chloride 6-Hydrate Crystal 500GAvantor is recalling Magnesium Chloride 6-Hydrate Crystal 500G bottles (NDC 10106-2448-1) due to subpotency.
FDA•LOWRemedy Gel Hydrocortisone 1%Island Kinetics is recalling Remedy Gel hydrocortisone 1% due to subpotency.
3 products
FDA•LOWGelatin Capsule Pack for Sodium Iodide I-131 KitInternational Isotopes recalling Gelatin Capsule Packs (NDC 69208-003-15/25/35) for Sodium Iodide I-131 Kit due to failed specifications.
FDA•LOWNilotinib Capsules 150 mgCipla is recalling Nilotinib Capsules 150 mg due to failed stability specifications observed during long-term testing.
2 products
FDA•LOWEptifibatide Injection 75 mg/100 mLSlate Run Pharmaceuticals recalls Eptifibatide Injection 75 mg/100 mL vials (NDC 70436-027-80, 70436-163-80) due to incorrect dosing-route labeling.
FDA•LOWPitavastatin Tablets, 2 mgNorthstar Rx LLC is recalling Pitavastatin Tablets, 2 mg (NDC 72603-479-01) due to a foreign 1 mg tablet found in bottles.
FDA•LOWDoxazosin Tablets, USP 4 mgUnichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.